Sage Therapeutics
SAGE
SAGE was delisted on the 30th of July, 2025.
73 hedge funds and large institutions have $735M invested in Sage Therapeutics in 2014 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 6 closing their positions.
367% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 6
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
160% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 10
40% more funds holding
Funds holding: 52 → 73 (+21)
23% more capital invested
Capital invested by funds: $596M → $735M (+$140M)
Top Buyers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$11.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.09M |
| 3 |
JP Morgan Chase
New York
|
+$4.45M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$4.03M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$3.74M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$7.01M |
| 2 |
PA
Perceptive Advisors
New York
|
-$5.15M |
| 3 |
O
OrbiMed
New York
|
-$4.66M |
| 4 |
Millennium Management
New York
|
-$2.52M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.94M |
SAGE Hedge Fund Activity: Q4 2014 in Review
73 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2014, worth a combined $735M — up 23% from $596M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new SAGE positions and 6 closed out — a net gain of 22 holders — while 26 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $11.9M. The largest seller was Deerfield Management, cutting an estimated $7.01M.
- 73 institutional investors held Sage Therapeutics (SAGE) as of Q4 2014, up from 52 in Q3 2014.
- Funds reported $735M of Sage Therapeutics stock for Q4 2014, up 23% quarter-over-quarter.
- 28 funds opened new Sage Therapeutics positions in Q4 2014 and 6 closed out, a net change of +22 holders.
- The largest Sage Therapeutics buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $11.9M added.
- The largest Sage Therapeutics seller in Q4 2014 was Deerfield Management, an estimated $7.01M sold.
Based on aggregated 13F filings for Q4 2014.